Comment on “Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective”

Detalles Bibliográficos
Autor principal: Gandjour, Afschin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363299/
https://www.ncbi.nlm.nih.gov/pubmed/35851443
http://dx.doi.org/10.1007/s40273-022-01170-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363299/
https://www.ncbi.nlm.nih.gov/pubmed/35851443
http://dx.doi.org/10.1007/s40273-022-01170-6

Ejemplares similares